Gen Surg Cases · surgical-critical-care
Blunt polytrauma with pelvic fracture and hypotension — MTP, whole blood, calcium and TXA timing
Fellowship clinical-management station on blunt-hemorrhage massive transfusion: trigger scores, PROPPR ratios with plasma-first sequencing, whole-blood selection in hypotension, CRASH-2 TXA timing, calcium replacement, targeted fibrinogen and early VTE vigilance.
On this page
Study tools
Target exams
Management walkthrough
Activate the MTP now — physiology plus mechanism plus FAST, scored formally. Systolic pressure 80 with tachycardia, unstable pelvis and positive FAST on 2 units meets every clinical trigger layer, and trigger-meeting patients given 1 to 3 units carry no excess harm signal — waiting for laboratories is the error, not activation.[9] Score it while transfusing: TASH most validated, ABC without laboratories, shock index on vitals with fair performance.[6] Resuscitate 1:1:1 plasma-platelets-red cells fast — exsanguination 9.2% vs 14.6% and haemostasis 86% vs 78% with complications equal — sequencing plasma early and delivering blood to the bay without delay.[1][25][8]
Choose whole blood first at systolic pressure 80. He sits squarely in the verified benefit subgroup: no overall adjusted mortality difference across all comers, but SBP below 90 carries aOR 0.72 and below 70 aOR 0.64 for whole blood versus components.[19] Give low-titre O whole blood first where the bank holds it; otherwise reconstituted 1:1:1 — and state the observational limit rather than promising trial proof.[19][1] Either way, limit crystalloid and accept permissive hypotension to haemostasis in this blunt non-brain-injured bleeder: in-hospital death 6.3% vs 16.3% with fewer respiratory, organ-failure and DIC complications.[24]
TXA 1 g with the first blood — 50 minutes is inside the best window. Dose 1 g loading over 10 minutes then 1 g over 8 hours: all-cause 14.5% vs 16.0%, bleeding death 4.9% vs 5.7%.[2] At 50 minutes he is inside the within-1-hour band (RR 0.68) and the pooled within-2-hours optimal criterion — after 3 hours the same drug carries a harm signal (RR 1.44), so the loading dose runs now, not after theatre.[3][4]
Replace calcium by level; ration fibrinogen by level with bleeding. Ionised 0.95 meets verified hypocalcaemia (1.0 or less): plasma-associated hypocalcaemia runs 53% vs 36% with survival tied to severe lows, while arrival means of 1.08 regardless show shock contributes — so give calcium under citrate load and recheck each round.[14][16] Check fibrinogen with the first round and replace documented low-with-bleeding by protocol — never empirically for every activation, because 6-g-equivalent empirical cryoprecipitate changed 28-day death not at all (25.3% vs 26.1%) and five randomised trials total OR 1.03.[10][11]
After haemostasis: pelvis, prophylaxis and disposition. Definitive pelvic control (binder to frame/external fixation per orthopaedics, angioembolisation on contrast blush), tibial washout and fixation once perfused, ICU with surgical and transfusion-medicine input — and VTE prophylaxis from the moment bleeding allows, because 13% of balanced-resuscitation patients develop VTE with pulmonary embolus predominant in the first 72 hours.[21] Re-escalation triggers are written (pressure, lactate, drain output, calcium, fibrinogen, respiratory status), not assumed.
References15ShowHide
- [1]Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA, 2015.PMID 25647203
- [2]Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet, 2010.PMID 20554319
- [3]Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet, 2011.PMID 21439633
- [4]Osawa I, Goto T, Roberts I, et al. Tranexamic acid for trauma: optimal timing of administration based on the CRASH-2 and CRASH-3 trials. Br J Surg, 2025.PMID 40277024
- [6]Shih AW, Al Khan S, Wang AY, et al. Systematic reviews of scores and predictors to trigger activation of massive transfusion protocols. J Trauma Acute Care Surg, 2019.PMID 31454339
- [8]Meneses E, Boneva D, McKenney M, et al. Massive transfusion protocol in adult trauma population. Am J Emerg Med, 2020.PMID 33071074
- [9]Gelbard RB, Griffin RL, Reynolds L, et al. Over-transfusion with blood for suspected hemorrhagic shock is not associated with worse clinical outcomes. Transfusion, 2022.PMID 35753037
- [10]Davenport R, Curry N, Fox EE, et al. Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury: The CRYOSTAT-2 Randomized Clinical Trial. JAMA, 2023.PMID 37824155
- [11]Burt T, Guilliam A, Cole E, et al. Effect of early administration of fibrinogen replacement therapy in traumatic haemorrhage: a systematic review and meta-analysis of randomised controlled trials with narrative synthesis of observational studies. Crit Care, 2025.PMID 39875966
- [14]Moore HB, Tessmer MT, Moore EE, et al. Forgot calcium? Admission ionized-calcium in two civilian randomized controlled trials of prehospital plasma for traumatic hemorrhagic shock. J Trauma Acute Care Surg, 2020.PMID 32317575
- [16]Rushton TJ, Tian DH, Baron A, et al. Hypocalcaemia upon arrival (HUA) in trauma patients who did and did not receive prehospital blood products: a systematic review and meta-analysis. Eur J Trauma Emerg Surg, 2024.PMID 38319350
- [19]Torres CM, Stolarski AE, Kenzik KM, et al. Identifying trauma patients who benefit from whole blood transfusion: An effect decomposition analysis on patient survival. Transfusion, 2025.PMID 40717387
- [21]Myers SP, Brown JB, Leeper CM, et al. Early versus late venous thromboembolism: A secondary analysis of data from the PROPPR trial. Surgery, 2019.PMID 31230842
- [24]Indorewala Y, Nasef Y, Jayagopi K, et al. Permissive hypotension in adult trauma: A systematic review of outcomes across clinical settings, injury type, and resuscitation strategies. Am J Emerg Med, 2026.PMID 42030689
- [25]Hynes AM, Westein RJ, Turner TJ, et al. Fresh frozen plasma-first approach is independently associated with improved survival in severely injured patients undergoing massive transfusion. J Trauma Acute Care Surg, 2026.PMID 42275580